Report Detail

Request for Sample of this report

Global Bioresorbable Medical Material Market Professional Survey Report 2019

RnM3850408
12 December, 2019
Global
102 Pages
XYZResearch
Pharma & Healthcare

In this report,global Bioresorbable Medical Material Market will reach 1553.59 Million USD by the end of 2022 with a CAGR of 7.86%

The Global Bioresorbable Medical Material Market is valued at 1064.28 Million USD in 2017 and will reach 1553.59 Million USD by the end of 2022, growing at a CAGR of 7.86% during 2017-2022.

Bioresorbable vascular scaffolds (BVSs) are designed to force open occluded arteries and restore blood flow. Composed of polylactic acid, these devices have been used to treat roughly 150,000 patients worldwide.

Bioresorbable Medical Material can be divided into six categories: PLA type, PGA type, PCL type, PLGA type, Polysaccharides type and other types. PLA type accounted for the highest proportion in sales market, with a figure of 27.38% in 2017, followed by PCL type, account for 18.85% and PGA type account for 15.83%.

The sales market share of global Bioresorbable Medical Material in Orthopedics use, Drug Delivery use and other applications have been stable year by year, at 43.70%, 38.14% and 18.16% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Bioresorbable Medical Material in the global market tends to be fixed without great changes. Among them, the Bioresorbable Medical Material market has the most promising sales prospects in Orthopedics use.

XYZ research center data shows that USA is the biggest contributor to the Bioresorbable Medical Material revenue market, accounted for 41.25% of the total global market with a revenue of 439.06 million USD in 2017, followed by Europe, 32.51% with a revenue of 346.03 million USD.

Evonik is the largest company in the global Bioresorbable Medical Material market, accounted for 30.53% of the revenue market share in 2017, followed by Corbion and DSM, accounted for 12.87% and 8.12% of the revenue market share in 2017. These manufacturers range from large multinational corporations to small privately owned companies compete in this industry, the leading company among them hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The top five producers account for above 60 % of the revenue market.

This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Evonik
Corbion
DSM
MitsuiChemicals
PCAS
Poly-Med
KLS Martin
...

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA

By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Drug Delivery
Orthopedics
Others

By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.